Sprint Bioscience AB (publ)

OM:SPRINT Stock Report

Market Cap: SEK 110.5m

Sprint Bioscience Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of SPRINT?
Owner TypeNumber of SharesOwnership Percentage
VC/PE Firms9,907,47114.2%
General Public12,466,98417.9%
Institutions12,643,12218.1%
Individual Insiders34,802,51349.8%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 22 shareholders own 82.14% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
15.1%
Rune Nordlander
10,562,553SEK 16.7m0%no data
14.2%
First Venture Sweden AB (publ)
9,907,471SEK 15.7m0%67.49%
9.71%
Nordnet Pensionsförsäkring Ab, Asset Management Arm
6,780,287SEK 10.7m0%0.2%
9.41%
Jan Nordqvist
6,573,470SEK 10.4m0%no data
9.02%
Mats Westinius
6,300,000SEK 10.0m0%no data
6.93%
Harri Salminen
4,841,391SEK 7.7m0%no data
6.19%
Avanza Fonder AB
4,322,447SEK 6.8m0%0.01%
2.59%
Staffan Halldin
1,811,200SEK 2.9m0%no data
2.2%
Nordea Liv Pension plan
1,532,649SEK 2.4m0%4.64%
1.64%
Håkan Roos
1,148,162SEK 1.8m0%no data
1.26%
Bjorn Sjostrand
882,354SEK 1.4m0%no data
0.91%
Pär Nordlund
638,085SEK 1.0m0%no data
0.77%
Dragan Vergic
537,700SEK 850.6k0%no data
0.64%
Salvador Lavado
444,494SEK 703.2k0%no data
0.61%
Pia Althin
424,313SEK 671.3k0%no data
0.39%
Martin Andersson
273,742SEK 433.1k0%no data
0.26%
Anne-Marie Wenthzel
178,049SEK 281.7k0%no data
0.1%
Mathias Skalmstad
72,000SEK 113.9k0%no data
0.072%
Fredrik Lehmann
50,000SEK 79.1k0%no data
0.064%
Svein Mathisen
45,000SEK 71.2k0%no data
0.029%
Johan Emilsson
20,000SEK 31.6k0%no data
0.011%
FCG Fonder AB
7,739SEK 12.2k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/30 11:23
End of Day Share Price 2024/12/30 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Sprint Bioscience AB (publ) is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Siri LadowDanske Bank
Christian BinderRedeye
Johan UnnerusRedeye